Free Trial
OTCMKTS:SGIOY

Shionogi & Co., Ltd. Unsponsored ADR Q3 2025 Earnings Results & Report

Shionogi & Co., Ltd. Unsponsored ADR logo
$9.95 +0.09 (+0.86%)
As of 11:10 AM Eastern

Shionogi & Co., Ltd. Unsponsored ADR reported Q3 2025 earnings on January 31, 2025. The company reported EPS of $0.16.

Earnings Announcement Details

Quarter
Q3 2025
Report Date
Time
Before Market Opens

Shionogi & Co., Ltd. Unsponsored ADR EPS Results

Actual EPS
$0.16
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
5 of last 8 quarters

Shionogi & Co., Ltd. Unsponsored ADR Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Shionogi & Co., Ltd. Unsponsored ADR's next earnings date is estimated for Friday, January 29, 2027, based on past reporting schedules.

Conference Call Resources

Shionogi & Co., Ltd. Unsponsored ADR Q3 2025 Earnings FAQ

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) reported earnings of $0.16 per share for Q3 2025. The report was announced on Friday, January 31, 2025.

Shionogi & Co., Ltd. Unsponsored ADR's next earnings date is estimated for Friday, January 29, 2027. MarketBeat tracks confirmed and estimated earnings dates for Shionogi & Co., Ltd. Unsponsored ADR on the company's earnings history page.

Shionogi & Co., Ltd. Unsponsored ADR Earnings Headlines

SHIONOGI & CO LTD
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
See More Shionogi & Co., Ltd. Unsponsored ADR Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Shionogi & Co., Ltd. Unsponsored ADR? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Shionogi & Co., Ltd. Unsponsored ADR and other key companies, straight to your email.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co., Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines. Founded in Osaka in 1878, it has grown from a pharmaceutical wholesaler into a research-focused drugmaker.

The company has a particular focus on infectious diseases, including HIV, influenza and COVID-19, and also works in areas such as pain and central nervous system disorders. Its products include Xofluza, an influenza treatment, and ensitrelvir, an oral COVID-19 antiviral marketed in Japan as Xocova.

Shionogi serves patients in Japan and international markets through its own operations and collaborations with other pharmaceutical companies. Its partnerships have supported the development and commercialization of medicines in areas including HIV treatment.

View Shionogi & Co., Ltd. Unsponsored ADR Profile